首页> 美国卫生研究院文献>Human Molecular Genetics >Inhibiting the ubiquitin–proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments
【2h】

Inhibiting the ubiquitin–proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments

机译:抑制泛素-蛋白酶体系统会导致有毒的N末端突变亨廷顿蛋白片段优先积累

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An expanded polyglutamine (polyQ) domain in the N-terminal region of huntingtin (htt) causes misfolding and accumulation of htt in neuronal cells and the subsequent neurodegeneration of Huntington's disease (HD). Clearing the misfolded htt is critical for preventing neuropathology, and this process is mediated primarily by both the ubiquitin–proteasome system (UPS) and autophagy. Although overexpression of mutant htt can inhibit UPS activity in cultured cells, mutant htt does not inhibit global UPS activity in the brains of HD transgenic mice. These findings underscore the importance of investigating the function of the UPS and autophagy in the brain when mutant proteins are not overexpressed. When cultured PC12 cells were treated with either UPS or autophagy inhibitors, more N-terminal mutant htt fragments accumulated via inhibition of the UPS. Furthermore, in HD CAG repeat knock-in mouse brain, inhibiting the UPS also resulted in a greater accumulation of N-terminal, but not full-length, mutant htt than inhibiting autophagy did. Our findings suggest that impairment of the UPS may be more important for the accumulation of N-terminal mutant htt and might therefore make an attractive therapeutic target.
机译:亨廷顿蛋白(htt)N端区域中扩展的聚谷氨酰胺(polyQ)域导致htt在神经元细胞中的错误折叠和积累,并随后导致亨廷顿舞蹈病(HD)的神经变性。清除错误折叠的htt对于预防神经病理学至关重要,该过程主要由泛素-蛋白酶体系统(UPS)和自噬介导。尽管突变型htt的过表达可以抑制培养细胞中的UPS活性,但突变型htt不能抑制HD转基因小鼠大脑中的整体UPS活性。这些发现强调了在突变蛋白未过表达时研究UPS的功能和在大脑中自噬的重要性。用UPS或自噬抑制剂处理培养的PC12细胞时,通过抑制UPS积累了更多的N端突变型htt片段。此外,在HD CAG重复敲入小鼠大脑中,抑制UPS也比抑制自噬导致N端(而非全长)突变体htt的积累更多。我们的发现表明,UPS的损伤对于N末端突变体htt的积累可能更为重要,因此可能成为有吸引力的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号